Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present

Current Opinion in Pulmonary Medicine
Thomas D ChaninFred R Hirsch

Abstract

Given the poor prognosis associated with lung cancer, the ability to diagnose lung cancer in its early stages is considered crucial to achieving decreased lung cancer mortality. Herein, we discuss recent advances in biomarker discovery and evaluation of their potential application in the clinical setting. Novel potential biomarkers have been identified via new techniques including cDNA microarray analysis, comparative genomic hybridization, and proteomics. These factors have been evaluated in various validation studies including tissue microarrays, RT-PCR, and assays of bioactivity. The characterization of these potential biomarkers through analysis of pathways that have been associated with neo-plastic transformation may help to identify the precursor lesions that are associated with subsequent progression to invasive carcinoma. In addition, the past year has also produced intriguing results regarding the detection of biomarkers in easily accessible screening specimens such as sputa, serum, and exhaled breath. Recent advances in these aspects of biomarker identification for the early detection of lung cancer are reviewed. Identification of new candidate biomarkers and improved applications of previously detected biomarkers sho...Continue Reading

References

Mar 1, 1990·The American Review of Respiratory Disease·P LangeP Schnohr
Nov 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S TockmanJ L Mulshine
Sep 8, 1997·The Journal of Cell Biology·K AingerJ H Carson
Aug 26, 1998·Human Pathology·R J SlebosW H Westra
Apr 28, 1999·Journal of the National Cancer Institute·S LamA F Gazdar
Aug 30, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·T YokoseA Ochiai
Sep 29, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J J BechtelG Saccomanno
Mar 10, 2001·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·M MoriA E Fraire
Apr 18, 2001·Journal of Clinical Pathology·K M Kerr
Jul 27, 2001·Disease-a-month : DM·T L Petty
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·S BotaL Thiberville
Sep 18, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Gabriella SozziGiuseppe Calarco
Nov 26, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Rob J van KlaverenFred R Hirsch
Mar 28, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Masaki TominagaEisaburo Sueoka
Apr 15, 2003·The Journal of Pathology·D R J SneadH Kamma
May 31, 2003·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Li-Fang ZhangPhouthone Keohavong
Jun 5, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Tatyana A ZhukovMelvyn S Tockman
Jun 11, 2003·Chest·Michael PhillipsWilliam N Rom
Jun 14, 2003·Current Opinion in Pulmonary Medicine·Thomas L Petty
Jun 24, 2003·The American Journal of Pathology·Chuan-Mu ChenTim Hui-Ming Huang
Jul 2, 2003·Biosensors & Bioelectronics·Corrado Di NataleArnaldo D'Amico
Jul 23, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Shulin WuTakashi Kondo
Aug 5, 2003·The Journal of Pathology·M A LevershaJ K Field
Aug 21, 2003·Lancet·Kiyoshi YanagisawaDavid P Carbone
Sep 26, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gabriella SozziUgo Pastorino
Sep 26, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul J Bunn
Oct 22, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Klaus KayserHans-Joachim Gabius
Nov 6, 2003·Journal of Clinical Pathology·F B J M Thunnissen
Nov 18, 2003·International Journal of Cancer. Journal International Du Cancer·Francesca AndrianiUgo Pastorino

❮ Previous
Next ❯

Citations

Jul 17, 2008·Comparative and Functional Genomics·J S AlmeidaG Warr
Apr 27, 2005·Brain Research. Brain Research Reviews·Lap HoGiulio Maria Pasinetti
Oct 30, 2013·Disease Markers·Chia-Cheng TsengMeng-Chih Lin
Mar 26, 2005·American Journal of Respiratory and Critical Care Medicine·Gorka BastarrikaJavier J Zulueta
Sep 24, 2005·American Journal of Respiratory and Critical Care Medicine·S M Jamshedur RahmanPierre P Massion
Apr 8, 2009·Proceedings of the American Thoracic Society·Sebahat OcakPierre P Massion
Oct 24, 2006·International Journal of Cancer. Journal International Du Cancer·Adrian CassidyJohn K Field
May 31, 2007·Current Opinion in Pulmonary Medicine·Alissa K Greenberg, M Sung Lee
Oct 25, 2007·Journal of Cellular Biochemistry·Meng Qiao, Arthur B Pardee
Mar 14, 2008·ChemMedChem·Hui William ChenWeihong Tan
Oct 20, 2006·Critical Reviews in Clinical Laboratory Sciences·Qinghua FengNancy B Kiviat
Dec 19, 2006·Critical Reviews in Clinical Laboratory Sciences·Catherine J LeeDavid A Fishman
Nov 25, 2014·Cancer Prevention Research·Brian M NolenAnna E Lokshin
Jul 22, 2011·Chemical Reviews·Sunil K Arya, Shekhar Bhansali

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.